This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Bruker Corporation's Management Presents At Goldman Sachs Healthcare Conference - Conference Call Transcript

Bruker Corporation (BRKR)

Goldman Sachs Healthcare Conference

June 5, 2012 5:00 p.m. EDT

Executives

Isaac Ro – Goldman Sachs, Analyst

Stacey Desrochers – Burker Corporation, IR Director

Analysts

No Analysts

Presentation

Isaac Ro

Okay, let’s get started here. Thanks for joining us here after lunch. I'm Isaac Ro, analyst here at Goldman. And I'm happy to have Stacey Desrochers from Bruker here to talk about the company.

And for those of you who are not familiar, the company has actually had a very busy start to the summer here. You had a big showing at the ASMS Conference. You had your first-ever investor meeting last week in New York. So there’s a lot of new stuff going on, and the stock’s had a pretty good run here with lots of improvements to the franchise over the last couple of years.

So, certainly, happy to take any questions throughout the course of the next 30 or 40 minutes. If you have them, please just raise your hand.

And with that as backdrop, let me just start by saying, thanks for coming, and feel free to give us a couple minutes update for the takeaways on the analyst meeting, if you like, and the key areas of focus for the balance of the year.

Stacey Desrochers

So, Bruker Corporation is a life science tools company. As Isaac said, we had our first Analyst Day ever last Friday in New York. It was well-attended, webcast and out there for folks if you want to listen to it. But we highlighted technologies and the new businesses that we acquired in 2010.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs